ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, vol.107, no.3, pp.266-272, 2011 (SCI-Expanded)
Background: The safety of long-acting beta-2-adrenergic agonists is increasingly questioned by physicians. Although formoterol is frequently used in childhood, its effects on the autonomic cardiovascular system have not been studied.